Seyed Amir Hejazi

ORIGINAL ARTICLE: Saffron in the treatment of patients with mild to moderate Alzheimer’s disease: a 16-week, randomized and placebo-controlled trial

Shahin Akhondzadeh, Mohammad Sabet, Mohammad-Hossein Harirchian et al. · Journal of Clinical Pharmacy and Therapeutics · 2010 · 243 citations

Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial

Samira Khani, Seyed Amir Hejazi, Mehdi Yaghoubi et al. · The Journal of Headache and Pain · 2021 · 34 citations · Full text

Migraine, dyspepsia, and Helicobacter pylori; zeroing in on the culprit

Nayereh Akbari, Ahmad Hormati, Ehsan Sharifipour et al. · Current Journal of Neurology · 2019 · 15 citations · Full text

A one year follow of patients with multiple sclerosis during COVID-19 pandemic: A cross-sectional study in Qom province, Iran

Sepideh Paybast, Seyed Amir Hejazi, Payam Molavi et al. · Multiple Sclerosis and Related Disorders · 2022 · 12 citations · Full text

Disease Progression, Medicine, Covid-19 Pandemic +7

Iranian Medical Universities in SCIE: evaluation of address variation

Farzaneh Aminpour, Payam Kabiri, Mohammad Ali Boroumand et al. · Scientometrics · 2010 · 10 citations

Education, Higher Education Management, Higher Education +2